PreveCeutical Medical Inc.
PREV
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.22M | -857.90K | -996.30K | -928.80K | -835.90K |
| Total Depreciation and Amortization | 7.70K | 7.40K | 7.40K | 7.30K | 7.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 376.30K | 287.20K | 269.70K | 267.20K | 272.90K |
| Change in Net Operating Assets | 490.30K | 251.60K | 427.30K | 408.20K | 362.60K |
| Cash from Operations | -341.00K | -311.60K | -291.80K | -246.00K | -193.00K |
| Capital Expenditure | -700.00 | -1.30K | -800.00 | -700.00 | -600.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.00K | -- | -- | -- | 2.40K |
| Cash from Investing | -40.70K | -1.30K | -800.00 | -700.00 | 1.80K |
| Total Debt Issued | 320.90K | 322.40K | 276.40K | 302.20K | 254.20K |
| Total Debt Repaid | -74.50K | -74.50K | -73.00K | -72.00K | -- |
| Issuance of Common Stock | 289.70K | 239.70K | 195.80K | 105.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 386.30K | 355.20K | 292.80K | 247.00K | 188.70K |
| Foreign Exchange rate Adjustments | -1.70K | -1.10K | -1.20K | -2.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.80K | 41.20K | -1.10K | -1.70K | -2.50K |